An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain
Clinical trial NCT05666687 · COMPLETED
Trial details
- NCT number
- NCT05666687
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-11
- Primary completion
- 2023-11-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.